IL-18CART,

Gabriel A Barragán Bravo1, David A de la Cerda1, Elisa Landoni2

  • 1Center for Advanced Innate Cell Therapy, Texas Children's Cancer Center; Department of Pediatrics, Baylor College of Medicine; Houston, Texas, 77030, USA.

概括

介质素-18 (IL-18) 增强了化学抗原受体 (CAR) - 不变的自然杀手T细胞 (NKT) 治疗癌症的作用. IL-18增强了CAR-NKT功能并控制了瘤,提供了一种有前途的下一代免疫治疗方法.